Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 14.00
0.00 (0.00%)
Aug 18, 2026, 11:17 AM CST
Feng Chi Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 156.99 | 177.36 | 171.1 | 180.58 | 193.46 | 182.57 |
Revenue Growth | -11.49% | 3.66% | -5.25% | -6.66% | 5.96% | 2.05% |
Gross Profit Gross Profit Growth | 70.45 | 79.16 | 77.15 | 80.72 | 83.44 | 86.11 |
Operating Income Operating Income Growth | 7.14 | 13.85 | 16.12 | 24.16 | 27.07 | 26.44 |
Net Income Net Income Growth | 9.91 | 14.47 | 16.59 | 22.79 | 24.61 | 23.14 |
Earnings Per Share EPS Growth | 0.65 | 0.94 | 1.07 | 1.47 | 1.60 | 1.50 |
EPS Growth | -30.99% | -12.16% | -27.21% | -8.03% | 6.55% | -8.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 171.85 | 178.13 | 207.18 | 215.93 | 234.9 | 230.27 |
Total Debt Total Debt Growth | 4.04 | 5.43 | 8.15 | 10.8 | 13.38 | 2.55 |
Net Cash (Debt) Net Cash Growth | 167.81 | 172.7 | 199.03 | 205.13 | 221.53 | 227.72 |
Net Cash Growth | -2.83% | -13.23% | -2.98% | -7.40% | -2.72% | 6.42% |
Net Cash Per Share Net Cash Per Share Growth | 10.95 | 11.18 | 12.87 | 13.27 | 14.32 | 14.73 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2.42 | 3.24 | 25.05 | 15.42 | 28.49 | 32.93 |
Capital Expenditures CapEx Growth | -0.7 | -13.02 | -14.59 | -1.4 | -0.09 | -1.1 |
Free Cash Flow Free Cash Flow Growth | 1.72 | -9.79 | 10.46 | 14.02 | 28.4 | 31.83 |
Free Cash Flow Growth | - | - | -25.42% | -50.63% | -10.78% | -12.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.87% | 44.63% | 45.09% | 44.70% | 43.13% | 47.16% |
Operating Margin | 4.55% | 7.81% | 9.42% | 13.38% | 13.99% | 14.48% |
Pretax Margin | 7.20% | 9.55% | 11.88% | 15.12% | 15.72% | 15.37% |
Profit Margin | 6.31% | 8.16% | 9.70% | 12.62% | 12.72% | 12.67% |
FCF Margin | 1.10% | -5.52% | 6.11% | 7.76% | 14.68% | 17.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.950 | - | 0.950 | 1.050 | 1.350 | 1.250 |
Dividend Per Share Growth | -11.58% | - | -9.52% | -22.22% | 8.00% | 8.70% |
Dividend Yield | 6.79% | - | 5.31% | 5.49% | 8.27% | 6.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.59 | 18.94 | 18.38 | 15.00 | 12.51 | 16.48 |
P/FCF Ratio | 125.20 | - | 29.16 | 24.39 | 10.85 | 11.98 |
PS Ratio | 1.37 | 1.55 | 1.78 | 1.89 | 1.59 | 2.09 |